Coronavirus: how llama blood could save seriously ill Covid patients
Tests show that antibodies from the South American camelids can prevent the virus from entering human cells
Antibodies taken from the blood of llamas can be engineered to target the Covid-19 coronavirus to create a treatment that could save countless lives, new research suggests.
Scientists led by a team from Oxford University have tested the virus-fighting potential of antibodies from Fifi, a llama living in Reading, in laboratory trials.
Transfusions of antibody-rich blood plasma from recovered Covid-19 patients are already being trialled in hospitals across the UK, “but the new findings herald the prospect of a more potent and easily available treatment”, The Telegraph reports.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Llamas, camels and alpacas “naturally produce quantities of small antibodies with a simple structure, meaning they can be turned into nanobodies”, the newspaper explains. The researchers found that these nanobodies bind tightly to the spike protein of Sars-CoV-2, the virus that causes Covid-19, which blocks and prevents the viral invader from entering human cells.
The team behind the study - outlined in a newly published paper in the journal Nature - hope that “llama-derived nanobodies could eventually be developed as a treatment for humans struck down with a severe case of Covid-19”, says the Daily Mail.
However, the research is still in a very early stage, with “academics at the Rosalind Franklin Institute at Oxford University condensing a process which would normally take almost a year into just 12 weeks”, the newspaper adds.
Study leader James Naismith, a professor of structural biology and director of the institute, said that the “nanobodies have the potential to be used in a similar way to convalescent serum, effectively stopping progression of the virus in patients who are ill”.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Joe Evans is the world news editor at TheWeek.co.uk. He joined the team in 2019 and held roles including deputy news editor and acting news editor before moving into his current position in early 2021. He is a regular panellist on The Week Unwrapped podcast, discussing politics and foreign affairs.
Before joining The Week, he worked as a freelance journalist covering the UK and Ireland for German newspapers and magazines. A series of features on Brexit and the Irish border got him nominated for the Hostwriter Prize in 2019. Prior to settling down in London, he lived and worked in Cambodia, where he ran communications for a non-governmental organisation and worked as a journalist covering Southeast Asia. He has a master’s degree in journalism from City, University of London, and before that studied English Literature at the University of Manchester.
-
Band Aid 40: time to change the tune?
In the Spotlight Band Aid's massively popular 1984 hit raised around £8m for famine relief in Ethiopia and the charity has generated over £140m in total
By Rebekah Evans, The Week UK Published
-
Starmer vs the farmers: who will win?
Today's Big Question As farmers and rural groups descend on Westminster to protest at tax changes, parallels have been drawn with the miners' strike 40 years ago
By The Week UK Published
-
How secure are royal palaces?
The Explainer Royal family's safety is back in the spotlight after the latest security breach at Windsor
By Chas Newkey-Burden, The Week UK Published
-
Long Covid: study shows damage to brain's 'control centre'
The Explainer Research could help scientists understand long-term effects of Covid-19 as well as conditions such as MS and dementia
By The Week UK Published
-
Israel, UN agree to Gaza pauses for polio vaccinations
Speed Read Gaza's first case of polio in 25 years was confirmed last week in a 10-month-old boy who is now partially paralyzed
By Rafi Schwartz, The Week US Published
-
FDA OKs new Covid vaccine, available soon
Speed read The CDC recommends the new booster to combat the widely-circulating KP.2 strain
By Peter Weber, The Week US Published
-
Mpox: how dangerous is new health emergency?
Today's Big Question Spread of potentially deadly sub-variant more like early days of HIV than Covid, say scientists
By The Week UK Published
-
What is POTS and why is it more common now?
The explainer The condition affecting young women
By Devika Rao, The Week US Published
-
Brexit, Matt Hancock and black swans: five takeaways from Covid inquiry report
The Explainer UK was 'unprepared' for pandemic and government 'failed' citizens with flawed response, says damning report
By Harriet Marsden, The Week UK Published
-
Should masks be here to stay?
Talking Points New York Governor Kathy Hochul proposed a mask ban. Here's why she wants one — and why it may not make sense.
By Anya Jaremko-Greenwold, The Week US Published
-
Covid might be to blame for an uptick in rare cancers
The explainer The virus may be making us more susceptible to certain cancers
By Devika Rao, The Week US Published